DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS
associated with 346 other trademarks
Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use for pharmaceutical research ...

Words that describe this trademark:

pharmaceutical research development  medical scientific research  pharmaceutical preparations  scientific research  research conducting  research development  preparations  relating  conducting  development 

Serial Number:

85525585

Mark:

DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS

Status:

Abandoned-No Statement of Use filed

Status Date:

09-22-2014

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use for pharmaceutical research and development

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Servicemark

Published for Opposition Date:

12-24-2013

Mark Drawing Status:

Standart Character Mark

Abandon Date:

09-22-2014

Business Name:

ASTRAZENECA PHARMACEUTICALS LLP

Correspondent Name:

Recent Trademark filings by this company